FundPlus

Fund+ is an open-ended fund for long-term equity investment in innovative Life Sciences companies with a focus on Belgium.

Fund+ invests in innovative Life Sciences companies with a focus on Belgium, aiming to create sustainable shareholder value and contribute to developing a leadership position in the Life Sciences sector. The fund generates a tangible, beneficial societal impact through its portfolio, which includes companies like Ona Therapeutics, Tubulis, and TargED Biopharmaceuticals.